| |
| |
|
| Insider
Information: |
Griffin Deborah A |
| Relationship: |
Chief Accounting Officer |
| City: |
Petach Tikva |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -13.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Teva Pharmaceutical Industries L... |
TEVA |
Chief Accounting Officer |
2020-03-17 |
0 |
2018-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2020-03-17 |
4 |
S |
$7.16 |
$6,762 |
D/D |
(944) |
0 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2020-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
944 |
944 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2020-03-04 |
4 |
S |
$11.23 |
$53,980 |
D/D |
(4,807) |
0 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2020-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,807 |
4,807 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2020-03-03 |
4 |
S |
$11.37 |
$13,253 |
D/D |
(1,166) |
0 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2020-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,166 |
1,166 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2020-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,941 |
2,941 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2020-03-02 |
4 |
S |
$11.60 |
$34,112 |
D/D |
(2,941) |
0 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2019-09-18 |
4 |
S |
$7.83 |
$18,607 |
D/D |
(2,376) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2019-09-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,376 |
2,376 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2019-03-18 |
4 |
S |
$16.63 |
$15,677 |
D/D |
(943) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2019-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
943 |
943 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2019-03-12 |
4 |
S |
$15.67 |
$14,938 |
D/D |
(953) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2019-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
953 |
953 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2019-03-04 |
4 |
S |
$16.88 |
$69,340 |
D/D |
(4,107) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2019-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,166 |
4,107 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2019-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,941 |
2,941 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2018-09-18 |
4 |
S |
$23.71 |
$56,328 |
D/D |
(2,376) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2018-09-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,376 |
2,376 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2018-03-19 |
4 |
S |
$17.88 |
$16,859 |
D/D |
(943) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2018-03-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
943 |
943 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2018-03-12 |
4 |
S |
$19.49 |
$18,554 |
D/D |
(952) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2018-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
952 |
952 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2018-03-05 |
4 |
S |
$19.38 |
$14,981 |
D/D |
(773) |
0 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2018-03-05 |
4 |
D |
$19.38 |
$7,616 |
D/D |
(393) |
773 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
